Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.
about
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling StudyReperfusion times of ST-Segment elevation myocardial infarction in hospitals.Trends in early aspirin use among patients with acute myocardial infarction in China, 2001-2011: the China PEACE-Retrospective AMI study.Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI StudyProjected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study.Quality of pharmacoeconomic research in China: A systematic reviewExamining the Impact of Rehospitalization on Healthcare Cost of Myocardial Infarction Patients in Beijing: A Retrospective Observational Study.Opportunities for improving global cardiovascular quality of care and outcomes.Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition.MiR-125b regulates SFRP5 expression to promote growth and activation of cardiac fibroblasts.Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations.
P2860
Q28546995-668E5E17-2FF1-4136-9AFD-144E5BD7089FQ35061034-547FF21E-97DF-4522-BF25-25D8726F1174Q35070605-9EDA4220-66FB-4378-8B2C-41C4967FB1F8Q35135680-6EC3261D-8367-4291-8F3B-5746473EBD07Q35913198-EB28ECC8-F389-49CD-8DA0-C97CE5C03F88Q37354823-6BF7BC21-02FA-4A6D-89B0-A47BF54A847DQ39172860-AD4D0AC6-8AD9-46DB-B7D7-ABFA81FD3D52Q43142042-C39A5AFA-B6F5-4541-A846-B1554F4FAAB8Q47721296-6B3560AD-A67F-4EDB-A478-D8A9D4E9D495Q51534500-BC0388A2-7D4C-41F2-89E5-A4EB07DC14E6Q55483901-A605C2F9-E633-47E0-A248-2630FBBCC7C9
P2860
Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost-effectiveness of optimal ...... rt disease mortality in China.
@ast
Cost-effectiveness of optimal ...... rt disease mortality in China.
@en
Cost-effectiveness of optimal ...... rt disease mortality in China.
@nl
type
label
Cost-effectiveness of optimal ...... rt disease mortality in China.
@ast
Cost-effectiveness of optimal ...... rt disease mortality in China.
@en
Cost-effectiveness of optimal ...... rt disease mortality in China.
@nl
prefLabel
Cost-effectiveness of optimal ...... rt disease mortality in China.
@ast
Cost-effectiveness of optimal ...... rt disease mortality in China.
@en
Cost-effectiveness of optimal ...... rt disease mortality in China.
@nl
P2093
P2860
P1476
Cost-effectiveness of optimal ...... rt disease mortality in China.
@en
P2093
Andrew E Moran
Dongfeng Gu
Lee Goldman
Pamela G Coxson
P2860
P356
10.1161/CIRCOUTCOMES.113.000674
P577
2014-01-14T00:00:00Z